Valuation: Amarin Corporation plc

Market Cap 292M 255M 236M 217M 410M 28.15B 419M 2.82B 1.11B 13.79B 1.1B 1.07B 47.46B P/E 2026 *
-465x
P/E 2027 * -697x
Enterprise Value 118M 104M 95.51M 88.04M 166M 11.41B 170M 1.14B 449M 5.59B 445M 435M 19.23B EV / Sales 2026 *
0.67x
EV / Sales 2027 * 0.66x
Free-Float
89.38%
Yield 2026 *
-
Yield 2027 * -
1 day-1.69%
1 week-6.32%
Current month-12.55%
1 month-13.04%
3 months-6.94%
6 months-5.68%
Current year-0.11%
1 week 13.94
Extreme 13.94
14.97
1 month 13.94
Extreme 13.94
17.25
Current year 12.96
Extreme 12.96
17.31
1 year 12.96
Extreme 12.96
20.9
3 years 7.08
Extreme 7.08
27.4
5 years 7.08
Extreme 7.08
119.4
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 2024-06-03
Director of Finance/CFO 42 2024-10-22
Compliance Officer 56 2023-11-14
Director TitleAgeSince
Director/Board Member 63 2024-06-03
Director/Board Member 47 2023-02-27
Chairman 51 2023-03-26
Date Insider Type Main position Quantity % Market Cap.
7/1/26 Fiscal year

Chief Technology Officer

9,263 0.0022%
7/1/26 Fiscal year

Chief Operating Officer

9,302 0.0022%
7/1/26 Fiscal year

Chief Financial Officer

6,100 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.69%-6.32%-11.88%-51.26% 292M
+0.24%-1.54%+52.85%+71.85% 53.83B
-7.17%-4.39%+42.72%+73.32% 52.1B
+0.80%-6.31%+5.62%+417.78% 23.48B
-0.09%-0.01%-16.85%-15.41% 23.13B
-5.95%-2.58%+29.53%-9.47% 19.36B
-1.14%+0.03%+31.67%-30.65% 17.56B
-5.16%-7.00%+168.44%+314.96% 15.2B
-6.91%-5.83%+25.17%+644.30% 14.83B
+0.43%-1.03%+25.75%+189.74% 14.06B
Average -2.66%-2.99%+35.30%+160.52% 23.38B
Weighted average by Cap. -2.80%-2.36%+39.48%+142.88%

Financials

2026 *2027 *
Net sales 178M 155M 143M 132M 249M 17.12B 255M 1.71B 674M 8.39B 668M 653M 28.87B 159M 139M 128M 118M 223M 15.3B 227M 1.53B 602M 7.49B 596M 583M 25.79B
Net income -12.75M -11.14M -10.28M -9.47M -17.86M -1.23B -18.25M -123M -48.32M -601M -47.87M -46.82M -2.07B -9.04M -7.9M -7.29M -6.72M -12.66M -870M -12.94M -87.11M -34.26M -426M -33.94M -33.2M -1.47B
Net Debt -174M -152M -140M -129M -244M -16.74B -249M -1.68B -659M -8.2B -653M -639M -28.23B -187M -164M -151M -139M -263M -18.06B -268M -1.81B -711M -8.84B -704M -689M -30.44B
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
26-07-17 $13.94 -1.69% 43,263
26-07-16 $14.18 -1.94% 56,405
26-07-15 $14.46 +0.63% 116,045
26-07-14 $14.37 -2.24% 51,974
26-07-13 $14.70 -1.21% 83,477
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
13.94USD
Average target price
12.00USD
Spread / Average Target
-13.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock